Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts

31 May 2023

Abstract excerpt

Background Extensive research has established the significant correlations between cancer-associated fibroblasts (CAFs) and various stages of cancer development, including initiation, angiogenesis, progression, and resistance to therapy. In this study, we aimed to investigate the characteristics of CAFs in lung adenocarcinoma (LUAD) and develop a risk signature to predict the prognosis of patients with LUAD....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37325647
DOI: 10.3389/fimmu.2023.1201573

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblastsPMID 37325647Read ↗

RNA-seq and bulk RNA-seq data analysis of cancer-related fibroblasts (CAF) in LUAD to construct a CAF-based risk signatureSemantic proximity Read ↗

Single-cell and bulk RNA analysis identifies EMT-associated CAF signatures and prognostic model in lung adenocarcinomaSemantic proximity Read ↗

Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq dataSemantic proximity Read ↗

Construction of a prognostic model for lung adenocarcinoma tumor endothelial cells and prediction of immunotherapy based on single-cell transcriptome and Bulk transcriptomeSemantic proximity Read ↗

A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma.Semantic proximity Read ↗

A novel basement membrane-related gene signature for prognosis of lung adenocarcinomasSemantic proximity Read ↗

An Integrative Machine Learning Approach Identifies a Cancer- Associated Fibroblast–Driven Predictive Model for Early-Stage Lung Squamous Cell CarcinomaSemantic proximity Read ↗

Characterizing Tumor Microenvironment and Risk Genes in Lung Adenocarcinoma through scRNA-seq and Bulk RNA-seq DataSemantic proximity Read ↗

Profiling Cancer-Associated Fibroblasts (CAFs) in Gastric Cancer and Development of a CAF-Based Prognostic Signature Using Integrated Single-Cell RNA Sequencing and TCGA AnalysisSemantic proximity Read ↗

Cancer-associated fibroblasts in early-stage lung adenocarcinoma correlate with tumor aggressivenessSemantic proximity Read ↗

Bulk and single-cell transcriptome profiling reveal tumor-specific T-based molecular classification, tumor microenvironment infiltration characterization relevant to combination therapies in lung adenocarcinomaSemantic proximity Read ↗

Development and Validation of a Prognostic Model for Lung Adenocarcinoma Based on CAF-Related Genes: Unveiling the Role of COX6A1 in Cancer Progression and CAF InfiltrationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.